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Abstract
Low-density lipoprotein (LDL)-cholesterol delivery from late endo-
somes to the plasma membrane regulates focal adhesion dynamics
and cell migration, but the mechanisms controlling it are poorly
characterized. Here, we employed auxin-inducible rapid degrada-
tion of oxysterol-binding protein-related protein 2 (ORP2/OSBPL2)
to show that endogenous ORP2 mediates the transfer of LDL-
derived cholesterol from late endosomes to focal adhesion kinase
(FAK)-/integrin-positive recycling endosomes in human cells. In vitro,
cholesterol enhances membrane association of FAK to PI(4,5)P2-
containing lipid bilayers. In cells, ORP2 stimulates FAK activation
and PI(4,5)P2 generation in endomembranes, enhancing cell adhesion.
Moreover, ORP2 increases PI(4,5)P2 in NPC1-containing late endo-
somes in a FAK-dependent manner, controlling their tubulovesicular
trafficking. Together, these results provide evidence that ORP2
controls FAK activation and LDL-cholesterol plasma membrane
delivery by promoting bidirectional cholesterol/PI(4,5)P2 exchange
between late and recycling endosomes.
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Introduction
Mammalian cells acquire cholesterol, a vital component of cell
membranes, via receptor-mediated uptake of low-density lipoprotein
(LDL) (Brown & Goldstein, 1986; Ikonen, 2008). The LDL-derived
cholesterol is released in the acidic endosomal milieu and two late
endosomal/lysosomal proteins, Niemann–Pick C1 (NPC1) and
Niemann–Pick C2 (NPC2), act in tandem to transfer cholesterol
from the organelle lumen to the limiting membrane (Kwon et al,
2009; Li et al, 2016; Qian et al, 2020). The LDL-derived cholesterol
is then transported to the plasma membrane (PM), to serve a struc-
tural role as a major PM constituent. PM cholesterol can be divided
into “accessible” and “inaccessible” pools based on its accessibility
to cholesterol-binding toxins (Das et al, 2014; Infante & Radhakrish-
nan, 2017). Cholesterol hydrolyzed from LDL in endo-lysosomes
adds to the accessible PM cholesterol pool (Das et al, 2014).
How LDL-cholesterol reaches the PM is not well understood. We
have reported that NPC1 organelles and LDL-cholesterol are trans-
ported toward the cell periphery via Rab8a-MyosinVb-actin-
dependent membrane trafficking (Kanerva et al, 2013). This route
delivers LDL-cholesterol to the PM in the proximity of focal adhe-
sions (FAs), stimulating FA dynamics and cell migration (Kanerva
et al, 2013). Which proteins are involved as actual cholesterol trans-
porters along this route after NPC1, is not clear. Moreover, the
precise interactions by which LDL-cholesterol facilitates cell migra-
tion remain largely unknown. The available evidence indicates that
cholesterol not only modulates membrane order in integrin-
mediated adhesion sites (Gaus et al, 2006; Lietha & Izard, 2020) but
also affects integrin recycling pathways (Reverter et al, 2014).
Several proteins with cytoplasmic cholesterol-binding domains
have been implicated in late endosomal cholesterol trafficking, but
none specifically at the stage of post-NPC1 LDL-cholesterol transport
leading to the PM. ORP2/OSBPL2 is a candidate for this, as it has
been related to cholesterol transport involving the PM (Laitinen
et al, 2002; Hynynen et al, 2005; Jansen et al, 2011; Koponen et al,
2019; Wang et al, 2019). Moreover, ORP2 can exchange cholesterol
for PI(4,5)P2, a PM enriched phosphoinositide (Wang et al, 2019).
According to recent data, PM cholesterol content was decreased and
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PI(4,5)P2 increased in ORP2 knockout HEK293 cells (Wang et al,
2019), whereas in ORP2-silenced endothelial cells, PM PI(4,5)P2
was increased without a significant change in the cholesterol
amount (Koponen et al, 2020). This leaves open the precise lipid
transport step(s) mediated by ORP2 and whether the primary func-
tion of ORP2 would be to control the level of cholesterol or PI(4,5)
P2 in the PM.
The challenges in assigning specific physiological lipid transport
steps for ORP2 in cells relate to the facts that endogenous ORP2 is
largely cytoplasmic (Laitinen et al, 2002) and that the lipid transfer
function of ORP2 does not require membrane anchoring (Wang et al,
2019). At the organismal level, human patients carrying ORP2 muta-
tions have been reported (Thoenes et al, 2015; Xing et al, 2015; Wu
et al, 2019), but they present with an unexpected phenotype, autoso-
mal dominant hearing loss, without providing an obvious indication
to the physiological function of the protein. In an attempt to pinpoint
the cellular lipid transfer steps that endogenous ORP2 is responsible
for, we have employed CRISPR-based gene editing to tag endogenous
ORP2 for fluorescent imaging and for acute protein degradation, using
a system we have recently developed (Li et al, 2019) and applied for
studying subcellular lipid trafficking (Salo et al, 2019).
Our studies provide evidence that LDL-derived cholesterol
spreads rapidly from late to recycling endosomal compartments on
its way to the PM. The transfer of cholesterol from late to recycling
endosomes is facilitated by ORP2 which counterexchanges it for PI
(4,5)P2. The ORP2-mediated bidirectional lipid exchange serves for
important cross-talk between late and recycling endosomes: LDL-
derived accessible cholesterol is transferred to the PM not only via
NPC1 late endosomes but also via FAK/integrin recycling endosomes
where it increases FAK activity. FAK activity and the generated PI
(4,5)P2 are in turn needed for maintaining NPC1 organelle dynamics.
Results
LDL enhances FA dynamics in a FAK-dependent manner
To visualize accessible cholesterol in cells upon LDL loading, we
purified a fluorescently tagged cholesterol-binding domain (D4H)
derived from Perfringolysin O (Maekawa & Fairn, 2015; Wilhelm
et al, 2017). The purified D4H bound specifically to cholesterol-
containing membranes (Fig EV1A). We then labeled A431 cells on
ice with the fluorescently tagged recombinant protein, fixed, and
imaged, essentially as previously described (Wilhelm et al, 2017)
(Fig 1A). In LDL-depleted conditions, D4H binding to the PM was
significantly decreased compared with complete medium, and upon
increasing times of LDL loading the signal gradually increased
(Fig 1B and C), in line with the notion that LDL-derived cholesterol
adds to the accessible cholesterol pool (Das et al, 2014).
To examine the role of LDL-cholesterol in FA dynamics, we gener-
ated cell lines stably expressing the FA proteins GFP-paxillin or
mCherry-talin and quantified FA assembly and disassembly rates
upon LDL loading (Figs 1D and E, and EV1B). We found that in both
cell lines LDL enhanced the assembly and disassembly of FAs in a
FAK-dependent manner, as the FAK inhibitor PF-228 or overexpres-
sion of a kinase dominant-negative mutant FAK Y397F, suppressed
the LDL-induced FA dynamics (Figs 1E and EV1C). Instead, choles-
terol removal by methyl-b–cyclodextrin (MbCD) inhibited FA assem-
bly and disassembly (Fig EV1D). The LDL-induced stimulation of FA
dynamics was observed from 1 h of LDL loading onwards and it was
abolished by NPC1 inhibition (Fig EV1E).
We also found that addition of LDL to LDL-depleted cells induced
an increase in FAK phosphorylation starting from ~ 0.5 h (Fig 1F).
In comparison, addition of cholesterol to cells directly from choles-
terol/cyclodextrin complex, which increases membrane cholesterol
content within minute(s), induced an increase in FAK phosphoryla-
tion within minutes (Fig EV1F). Together, these results are compati-
ble with the idea that cholesterol enhances FAK activation and that
in cells, LDL-derived cholesterol might reach FAK before its levels
are prominently increased at the cell surface.
LDL-cholesterol is delivered to
FAK/integrin-containing endosomes
In migrating cells, FAK co-localizes with recycling integrins, sustain-
ing them in the active conformation and polarizing them toward the
leading edge (Nader et al, 2016). We therefore studied how the orga-
nelles containing active FAK localize relative to NPC1-harboring
▸Figure 1. LDL enhances FA dynamics in a FAK-dependent manner.A Schematic outline of plasma membrane D4H labeling. CM and LPDS indicate complete medium (10% FBS in DMEM) and 5% LPDS in DMEM, respectively.
B After 24-h LDL depletion in 5% LPDS, cells were loaded with 50 lg/ml LDL for the indicated times. Plasma membrane cholesterol was labeled with D4H and imaged
with widefield epifluorescence microscopy.
C Analysis of (B). Mean  SD, n = 15 fields of cells as in (B) pooled from 2 independent experiments.
D Representative FA lifetime in cells treated without or with 50 lg/ml LDL (LDL or +LDL) for 1–2 h after 24 h in 5% LPDS. Time-lapse imaging of GFP-paxillin
dynamics in cells was acquired by TIRF microscopy and maximum intensity during FA lifetime was normalized to 1.
E Analysis of FA assembly and disassembly rate of cells incubated +/LDL as in (D). Where indicated, 10 lM PF-228 was added after 30 min of LDL loading. Assembly
rate: n = 290 FAs (LDL); 410 (+LDL); 192 (+LDL+PF-228) and disassembly rate: n = 397 (LDL); 502 (+LDL); 214 (+LDL+PF-228) pooled from 4 independent
experiments. The Tukey box plots represent the median and 25th and 75th percentiles (interquartile range). The whiskers show the highest and lowest observations.
Non-parametric Kruskal–Wallis analysis of variance with Bonferroni error correction.
F Representative immunoblot and quantification of pFAK levels in 5% LPDS (LDL) and upon increasing LDL loading times. Mean  SD, n = 3, paired Student’s t-test
(*P < 0.05).
G Representative confocal images of NPC1, internalized integrin b1, and pFAK localization. Stably NPC1-GFP-expressing cells were loaded with 2 lg/mL integrin b1
antibody for 30 min before fixation and stained with pFAK antibody followed by secondary antibodies. Dashed line indicates the cell edge.
H Quantification of (G) using Mander’s colocalization for the indicated markers. Mean  SD, n = 5 cells. Cells were treated with 5% LPDS for 1 day and then without
() or with (+) 50 lg/ml LDL for 1h.
Source data are available online for this figure.
2 of 20 The EMBO Journal 40: e106871 | 2021 ª 2021 The Authors











-LDL +LDL1h  +LDL2h +LDL4hCM
Live cell staining 
with D4H on ice
Fix with PFA
and mount






























































































































































































































ª 2021 The Authors The EMBO Journal 40: e106871 | 2021 3 of 20
Kohta Takahashi et al The EMBO Journal
organelles upon LDL loading. Cells stably overexpressing NPC1-GFP
were LDL-depleted and then loaded with LDL for 1–2 h, of which
the last 30 min in the presence of antibodies against integrin b1, to
trace the recycling integrins. Cells were then immunostained with
pFAK antibodies (Appendix Fig S1). pFAK and internalized integrin
b1 were often in overlapping vesicular structures as expected, but
NPC1 organelles did not colocalize with them (Fig 1G and H). Yet,
the NPC1 and FAK/integrin-containing endosomes were often in
close proximity to each other, with NPC1 endosomes sometimes
encircling pFAK/integrin-containing organelles (Fig 1G).
We have earlier reported that LDL particles labeled with
BODIPY-cholesteryl linoleate can be used to follow the export of
the fluorescent sterol from late endosomes and its delivery to the
PM or lipid droplets (Kanerva et al, 2013; Heybrock et al, 2019).
Using a similar strategy, we explored whether the LDL-derived
fluorescent sterol can be delivered to integrin b1-containing recy-
cling endosomes visualized by internalized fluorescently labeled
antibodies (Fig 2A). After 2 h labeling of cells with BODIPY-
cholesteryl linoleate/LDL, most of the label was in late endosomal
compartments labeled with fluorescent dextran (Fig EV2A), as
previously shown (Kanerva et al, 2013). However, roughly 20%
of LDL-derived BODIPY-cholesterol colocalized with recycling inte-
grin b1 and this fraction increased to ~ 60% during 1 h of chase
(Figs 2B and EV2B). Considering that integrin b1 may also be
found in late endosomes, at least when fibronectin is internalized
(Lobert et al, 2010), we also assessed the localization of LDL-
derived BODIPY-cholesterol relative to another recycling protein,
transferrin. Similarly, increasing colocalization between BODIPY-
cholesterol and fluorescent transferrin was observed at early times
of LDL chase (Fig EV2C–E). These data suggest that the fluores-
cent sterol deriving from LDL rapidly reaches recycling endosomal
compartments.
Fast frame-rate live-cell imaging revealed rapid and repeated
kiss-and-run type of contacts between the BODIPY-cholesterol and
integrin b1-containing organelles (Fig EV2F and Movie EV1). These
contacts were apparently engaged in sterol cargo exchange, as inte-
grin b1-positive organelles showed increased BODIPY-cholesterol
fluorescence after contacting BODIPY-cholesterol enriched orga-
nelles (Fig EV2G).
To circumvent caveats related to the use of fluorescent sterol
analogs, we also visualized intracellular, LDL-derived accessible
cholesterol using the D4H probe, as previously described (Wilhelm
et al, 2017) (Fig 2C). In LDL-depleted conditions, virtually no
intracellular accessible cholesterol was detectable (Fig 2D and E).
Upon increasing LDL loading (1–4 h), the intracellular D4H labeling
increased, first appearing as punctate structures at the perinuclear
region and then increasingly spreading toward the cell periphery
(Fig 2D and E). With increasing LDL loading, the total D4H area
overlapping with NPC1-GFP and especially with internalized inte-
grin b1 increased (Fig 2F and G), while the fraction of D4H co-
localizing with NPC1 decreased (Fig 2F and H), indicative of the
delivery of accessible LDL-derived cholesterol to post-NPC1 destina-
tions. These results agree with those obtained by following the itin-
erary of BODIPY-cholesteryl linoleate-labeled LDL and suggest that
LDL-derived accessible cholesterol spreads from NPC1 endosomes
toward the cell periphery reaching FAK/integrin endosomes on its
way to the PM.
FAK regulates cholesterol export from NPC1 endosomes and
endomembrane PI(4,5)P2 levels
We next investigated whether FAK activity is needed for LDL-
cholesterol PM delivery, taking advantage of the FAK inhibitor PF-
228, which blocks the cycle of FA turnover but did not inhibit LDL
uptake (Fig EV3A). Loading of LDL-deprived cells with LDL in
the presence of PF-228 resulted in reduced PM delivery of
LDL-cholesterol as assessed by PM D4H labeling (Fig EV3B and C).
Moreover, a prominent redistribution of the intracellular accessible
LDL-derived cholesterol pool was observed by the intracellular D4H
labeling protocol. Although the total D4H-labeled area increased
upon LDL loading in PF-228-treated cells, the increase was smaller
than in control cells (Fig 3A and B). The fraction of D4H overlap-
ping with NPC1 failed to decrease efficiently over time; rather, there
was a marked colocalization of NPC1-GFP and intracellular D4H
even after 4 h of LDL loading, which was hardly detectable in the
absence of the inhibitor (Fig 3A and C). In parallel, the spreading of
D4H labeling to the integrin b1 compartment was attenuated
(Fig 3A and D). Reduced PM delivery and late endosomal retention
of LDL-cholesterol was also observed in cells where FAK was
silenced (Figs 3E–G and EV3D and E), arguing that these pheno-
types in PF-228 treated cells are not due to unspecific drug effects.
Together, these findings provide evidence that LDL-derived acces-
sible cholesterol fails to efficiently exit NPC1 organelles if FAK is
not active.
While a role of FAK in endosomal cholesterol delivery was unex-
pected, FAK is known to control endomembrane PI(4,5)P2
▸Figure 2. LDL-cholesterol is rapidly delivered to FAK/integrin endosomes.A Outline of live-cell BODIPY-cholesteryl linoleate/LDL labeling and chase combined with AF680-integrin b1 antibody labeling. Cells were pre-treated for 1 day in 5%
LPDS.
B Quantification of the fraction of BODIPY-cholesterol (BC) fluorescence in integrin b1-positive organelles at the indicated chase times. Exemplary images are shown in
Fig EV2B. Mean  SEM, n = 8 (0 min); 6 (15 min); 5 (30 min); 6 (45 min); and 7 (60 min) cells from 3 independent experiments.
C Schematic outline of intracellular D4H labeling.
D After 1-day LDL depletion in 5% LPDS, cells were loaded with 50 lg/ml LDL for the indicated times and intracellular cholesterol was detected with D4H as in (C) by
confocal microscopy. CM, complete medium. Dashed lines indicate cell outlines.
E Quantification of (D). Mean  SD, n = 25–26 cells pooled from 2 independent experiments.
F Cells were treated for 1 day in 5% LPDS followed by 50 lg/ml LDL loading for the indicated times. Representative confocal images of cells triple labeled with
intracellular accessible cholesterol (D4H), NPC1-GFP and internalized integrin b1. Dashed lines indicate cell outlines.
G Quantification of D4H area positive for NPC1 or internalized integrin b1 in a peripheral region toward the leading edge (exemplary box shown as inset in (F)).
H Fraction of D4H area overlapping with NPC1 or internalized integrin b1 in a peripheral region toward the leading edge (exemplary box shown as inset in (F)).
Mean  SD, n = 27–30 cells pooled from 2 independent experiments. Student’s t-test.
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generation by activating type I phosphatidylinositol phosphate
kinase (PIPKIc) on endosomes (Nader et al, 2016) (Fig 3H). We
therefore investigated the effect of FAK on endomembrane PI(4,5)P2
distribution using anti-PI(4,5)P2 antibody staining, with a previously
validated protocol (Hammond et al, 2009). This revealed that FAK
inhibition with PF-228 indeed resulted in a pronounced reduction in
endomembrane PI(4,5)P2 levels (Fig 3I and J). Moreover, reduced
PM PI(4,5)P2 labeling upon PF-228 treatment was observed using
the PLCdelta PH domain as a sensor for this phosphoinositide (Fig
EV3F and G).
Endogenous ORP2 localization and acute removal by
auxin-inducible degradation
ORP2 has been implicated in cholesterol transport to the PM (Laiti-
nen et al, 2002; Hynynen et al, 2005; Koponen et al, 2019; Wang
et al, 2019). Accordingly, we found that ORP2 silencing by siRNA
decreased the PM accessible LDL-derived cholesterol (Fig EV4A and
B). Yet, these data do not pinpoint where the ORP2-mediated lipid
exchange takes place. To investigate the site of action of endoge-
nous ORP2, we tagged ORP2 at the genomic locus with GFP and
degron cassettes (Appendix Fig S2), so that the endogenous GFP-
tagged ORP2 can be visualized and acutely depleted using the auxin
(indole-3-acetic acid, IAA)-inducible degron (AID) system (Nishi-
mura et al, 2009; Li et al, 2019) (Fig 4A). With this system, IAA
induces rapid ORP2 removal in cells harboring the complete AID
machinery (ORP2-degron cells, > 95% reduction in endogenous
ORP2 protein in ~ 30 min), while IAA had no effect in control cells
lacking AtAFB2 expression (Fig EV4C).
When ORP2-degron and control cells were co-plated and then
treated with IAA for 1 h, the specific signal from endogenous GFP-
ORP2 in control cells was dim, but readily visible over the back-
ground (ORP2-depleted cells). GFP-ORP2 was observed as diffuse
cytoplasmic fluorescence and as small mobile punctate structures,
with no clear concentration in the PM (Fig 4B) or obvious change
upon LDL depletion/loading of cells (not shown). To examine the
relationship of endogenous GFP-ORP2 with NPC1 and FAK/integrin
endosomes, we reduced the cytosolic GFP-ORP2 signal by saponin
pre-permeabilization prior to fixation (Pfisterer et al, 2017),
followed by anti-GFP (to enhance the remaining ORP2 signal) and
pFAK, integrin b1, or NPC1 antibody labelings (Fig 4C–E). This
revealed that about half of the endogenous ORP2 signal was in
contact or overlapped with pFAK or integrin b1 and about 20% with
NPC1, suggesting that at steady state, a higher fraction of ORP2 was
associated with integrin/FAK than NPC1-containing endosomes
(Fig 4D). We also observed occasional concentrations of GFP-ORP2
between NPC1 and integrin b1-containing organelles, especially in
the cell periphery (Fig 4E).
Acute ORP2 removal impairs LDL-cholesterol delivery to the PM
and cell adhesion
We next studied the effects of acute ORP2 depletion in this system.
While LDL uptake was not affected by acute ORP2 removal
(Fig EV4D), a clear reduction in PM accessible LDL-derived choles-
terol was observed when IAA was added together with LDL, i.e.,
ORP2 was depleted in parallel with LDL loading for 1–4 h (Fig 4F
and G). Instead, under these conditions no effect was observed in
the delivery of LDL-cholesterol to the ER for suppression of SREBP2
target gene expression or for cholesterol re-esterification (Fig 4H–J).
Considering that ORP2 exchanges PI(4,5)P2, we also investigated
whether acute ORP2 degradation alters PM PI(4,5)P2. Based on
PLCdelta PH-domain distribution, no obvious changes in PM PI(4,5)P2
were observed during the first 4 h upon ORP2 removal; however,
after 3 days of ORP2 ablation, more PM PI(4,5)P2 was detected
(Fig EV4E–G), in consistence with cells silenced for ORP2 for 3 days
(Koponen et al, 2020). In addition, we tested whether a well-known
PM PI(4,5)P2-dependent membrane transport process, clathrin-
mediated endocytosis of transferrin was affected, and found it not to
be altered in 4 h of ORP2 removal (Fig EV4H). Together, these
results suggest that an increase in PM PI(4,5)P2 is not acute but
develops gradually upon ORP2 removal.
We also assessed whether ORP2 removal affects integrin-
dependent cell adhesion. We found that acute ORP2 depletion abol-
ished the LDL-induced increase in cell adhesion (as measured by cell
area at 1 h after replating, Fig EV4I–K). Of note, acute ORP2 removal
also inhibited cell adhesion in the absence of LDL, indicating that the
effect of ORP2 was not strictly LDL-dependent (Fig EV4K). The
impaired adhesion upon ORP2 removal agrees with earlier observa-
tions in ORP2 knockout hepatoma cells (Kentala et al, 2018).
Acute ORP2 removal impairs cholesterol transfer from late
endosomal organelles to integrin b1 recycling endosomes
To investigate endomembrane cholesterol distribution in acutely
ORP2-depleted cells, we visualized intracellular cholesterol with
▸Figure 3. FAK activity regulates cholesterol delivery to FAK/integrin endosomes and endomembrane PI(4,5)P2 levels.A After 1 day in 5% LPDS, NPC1-GFP expressing cells were loaded with 50 lg/ml LDL with or without 10 lM PF-228 for the indicated times, and stained for
intracellular D4H. Representative confocal images of intracellular D4H, NPC1-GFP, and internalized integrin b1 labeling. Dashed lines indicate cell outlines.
B Fraction of D4H-positive area in the cell as in (A).
C Fraction of D4H area overlapping with NPC1 in a peripheral region toward the leading edge (exemplary box shown as inset in (A)).
D Quantification of D4H area positive for integrin b1 in a peripheral region toward the leading edge. Mean  SD, n = 26–30 cells pooled from 2 independent
experiments. Student’s t-test.
E–G Control and FAK siRNA-treated cells were LDL depleted for 1 day, loaded with LDL for the indicated times, and stained for plasma membrane D4H or for
intracellular D4H with lamp1 or integrin b1 antibodies. Quantification of plasma membrane D4H (E) and intracellular D4H area positive for lamp1 (F) or integrin
b1 (G); corresponding images in Fig EV3D and E. Mean  SD, n = 20–35 cells from 2 independent experiments. Student’s t-test.
H Schematic of FAK-regulated PI(4,5)P2 generation on endosomes via PIPKIc, modified from (Nader et al, 2016).
I After 1-day 5% LPDS, cells were loaded with 50 lg/ml LDL with or without 10 lM PF-228 for the indicated times and endomembrane PI(4,5)P2 was stained with
antibody and imaged by confocal microscopy.
J Quantification of mean PI(4,5)P2 immunoreactivity in cells. Mean  SD, n = 16–26 cells pooled from 2 independent experiments. Student’s t-test.
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D4H as in Fig 2C. Control and degron-ORP2 cells were co-plated
and, after LDL depletion, treated for increasing times with LDL and
IAA. This revealed that the LDL-dependent increase in intracellular
accessible cholesterol was attenuated when ORP2 was missing
(Fig 5A and B). Antibody co-labelings revealed that the LDL-derived
accessible cholesterol signal was initially confined largely to Lamp1-
positive late endosomal/lysosomal organelles and that this fraction
decreased over time efficiently in control but not in ORP2-depleted
cells (Fig 5C and D; late endosomal compartments were detected
with Lamp1 rather than NPC1 antibodies, because the latter were
not compatible with liquid N2 permeabilization). In parallel, the
increase of D4H signal in integrin b1 compartments was not taking
place in ORP2-depleted cells (Fig 5E and F). To address whether
ORP2 modifies transient contacts between late and recycling
compartments, we carried out live-cell imaging of contacts between
dextran and transferrin-labeled endosomes before and after acute
ORP2 removal (BODIPY-cholesterol imaging in GFP-ORP2 cells was
not feasible due to overlapping fluorophores). This revealed that
ORP2 removal for 2–3 h led to fewer but prolonged contacts
between late and recycling compartments (Fig EV5A–C, Movies EV2
and EV3). Together, these data suggest that ORP2 controls the redis-
tribution of LDL-cholesterol from late endosomal compartments to
integrin-containing recycling endosomal compartments.
ORP2 regulates endomembrane PI(4,5)P2 and NPC1 distribution
in a FAK-dependent manner
Considering that ORP2 can function as a cholesterol and PI(4,5)P2
exchanger, we next investigated endomembrane PI(4,5)P2 distribu-
tion and its relationship to ORP2. Endosomal PI(4,5)P2 levels can be
increased by silencing of the inositol polyphosphate 5-phosphatase
OCRL (Vicinanza et al, 2011), as readily evident by the anti-PI(4,5)
P2 antibody labeling (Fig 6A). OCRL-deficient cells accumulate PI
(4,5)P2 both at early (Vicinanza et al, 2011) and late endocytic orga-
nelles (De Leo et al, 2016). Remarkably, in OCRL-silenced cells also
endogenous GFP-ORP2 was redistributed to the perinuclear region,
showing a pronounced colocalization with the PI(4,5)P2 labeling
(Fig 6A). This result indicates that endogenously expressed GFP-
ORP2 can be recruited to PI(4,5)P2 harboring endomembranes. LDL
loading of cells caused a moderate increase in endomembrane PI
(4,5)P2 labeling but the pattern was more scattered than upon OCRL
silencing (Fig EV5D and E). In contrast, in acutely ORP2-depleted
cells, LDL loading failed to increase the PI(4,5)P2 labeling (Fig EV5D
and E), suggesting that ORP2 is needed for the LDL-induced
endomembrane PI(4,5)P2 increase.
This prompted us to study the relationship between PI(4,5)P2
and NPC1 more closely. In OCRL-silenced cells, some of the perinu-
clear PI(4,5)P2 structures colocalized with NPC1-mCherry contain-
ing compartments (Fig 6B and C). Remarkably, overexpression of
GFP-ORP2 resulted in enhanced anti-PI(4,5)P2 labeling, with promi-
nent colocalization with NPC1 and peripheral redistribution of the
double labeled organelles (Fig 6B). This effect of ORP2 was depen-
dent on its PI(4,5)P2 binding capability, as overexpression of the PI
(4,5)P2 binding-deficient mutant (ORP2-mHHK) failed to increase
the PI(4,5)P2 labeling in NPC1 organelles (Fig 6B and C). Moreover,
FAK activity was also involved, as its inhibition attenuated the
ORP2-WT-induced increase of PI(4,5)P2 in these organelles (Fig 6B
and C).
To further investigate the effect of FAK and ORP2 on NPC1 orga-
nelles, we performed live-cell imaging of NPC1-mCherry expressing
cells. The NPC1-containing structures are known to undergo exten-
sive tubulation (Zhang et al, 2001); the tubulation, splitting, and
kiss-and-run events enable fission and exit of cargo from lysosomes
and related organelles (Saffi & Botelho, 2019). We found that FAK
inhibition exaggerated the tubulation of NPC1-mCherry containing
structures, as assessed by measuring the length of the longest tubule
per cell (Fig 6D and E and Movies EV4 and EV5). Despite this, the
delivery of NPC1 organelles to the cell periphery adjacent to FAs
(Kanerva et al, 2013) was defective (Fig EV5F and G), arguing that
the tubules may represent arrested carrier intermediates. The exces-
sive tubulation of NPC1 organelles upon FAK inhibition could be
rescued by overexpression of WT but not PI(4,5)P2-binding-
deficient mutant of ORP2 (Figs 6E and EV5H). Moreover, also when
endogenous ORP2 was acutely depleted from NPC1-mCherry
expressing cells, the NPC1 tubules became more elongated (Fig 6D
and E). These results suggest that FAK activity and ORP2 with its PI
(4,5,)P2 transfer activity are needed to prevent excessive appearance
of tubules in NPC1 organelles.
Cholesterol- and PI(4,5)P2 transfer-competent ORP2 enhances
FAK activation
Finally, since PI(4,5)P2 regulates the membrane association and
activation of FAK (Goni et al, 2014; Bauer et al, 2019; Acebron et al,
◀ Figure 4. Endogenous ORP2 localization and acute depletion via auxin-inducible degradation.
A Schematic of endogenous ORP2 tagging and auxin-inducible degron system.
B Control (endogenously GFP-tagged ORP2 without AtAFB2) and degron-ORP2 cells were co-plated and treated with IAA for 1 h followed by live-cell confocal
imaging. Dotted line separates GFP-ORP2 containing and depleted cells, asterisk indicates the area of ORP2-depleted cells, and inset shows no prominent PM
enrichment of endo-GFP-ORP2.
C Confocal image of endo-GFP-ORP2 and pFAK immunofluorescence staining in saponin pre-permeabilized cells loaded with LDL for 2 h before fixation. GFP antibody
was used to enhance endo-GFP-ORP2 signal. Insets show examples of “no contact”, “contact”, and “overlap” of organelles. Dashed line indicates cell edge.
D Quantification of pFAK, integrin b1, and NPC1 association with endo-GFP-ORP2 in C. n = 380 pFAK; 353 integrin b1; 232 NPC1 organelles in 2 cells.
E Representative confocal images of triple labeling for endogenous ORP2, NPC1-mCherry, and integrin b1 after 2 h of LDL loading, and saponin permeabilization prior
to fixation. Dashed line indicates cell edge.
F Schematic outline for plasma membrane D4H labeling in combination with ORP2-degron system, and representative widefield epifluorescent images of co-plated
cells after 4 h of LDL loading. Asterisk indicates ORP2-depleted degron cells. Dashed lines separate ORP2 expressing and depleted cells.
G Quantification of F. Mean  SD, n = 20 fields of cells pooled from 2 independent experiments. Student’s t-test.
H–J Control and degron-GFP-ORP2 cells were incubated in 5% LPDS for 1 day, loaded with LDL + IAA for the indicated times, and LDLR (H) and hydroxymethylglutaryl-
CoA reductase (HMGCR) (I) mRNA levels were quantified with qPCR or [3H]-oleic acid (OA) incorporation into cholesteryl esters (CE) was analyzed (J). Mean  SD,
n = 2–3 RNA samples from independent experiments with triplicate measurements (H, I); n = 3 (LDL and 6 h); n = 6 (all other time points) pooled from 2
independent experiments (J).
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2020) we studied whether ORP2 plays a role in FAK membrane
association and phosphorylation. LDL loading increased the pFAK
immunostaining of cells in line with the immunoblotting results
(Fig 1F), displaying a prominent intracellular punctate pattern, but
this effect was missing in acutely ORP2-depleted cells (Figs 7A and
B, and EV5I and J). The pFAK labeling was rescued by introduction
of wild-type ORP2 but not by the PI(4,5)P2- or sterol binding-
deficient mutants (Figs 7A and B, and EV5K). These data suggest
Control Degron ORP2
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Figure 5. Acute removal of endogenous ORP2 impairs LDL-cholesterol transfer from late endosomes to FAK/integrin endosomes.
A Control and degron-ORP2 cells were co-plated, and after 1-day incubation in 5% LPDS, cells were loaded with LDL (+LDL) and IAA (+IAA; ORP2 depletion) for the
indicated times. Intracellular cholesterol was labeled with D4H and imaged by widefield epifluorescence microscopy. Asterisk indicates region of ORP2-depleted
cells. CM, complete medium. Dashed lines separate ORP2 expressing and depleted cells.
B Quantification of (A). Mean  SD, n = 15–27 cells pooled from 2 independent experiments. Student’s t-test.
C–F Control and degron-ORP2 cells were co-plated, and after 1 day in 5% LPDS, treated with 50 lg/ml LDL and IAA for the indicated times. Asterisk indicates an ORP2-
depleted cell. Double labeling of intracellular D4H and Lamp1 (C) or intracellular D4H and internalized integrin b1 (E). Images were acquired by confocal
microscopy. Red box indicates a peripheral region toward the leading edge in the control cell, and blue box a corresponding region in the ORP2-depleted cell.
(D, F) Fraction of D4H area overlapping with lamp1 (D) and D4H area positive for internalized integrin b1 (F) in a peripheral region toward the leading edge
(exemplary box as inset). Mean  SD, n = 20–30 cells pooled from 2 independent experiments. Student’s t-test.
10 of 20 The EMBO Journal 40: e106871 | 2021 ª 2021 The Authors



























































































































































































































ª 2021 The Authors The EMBO Journal 40: e106871 | 2021 11 of 20
Kohta Takahashi et al The EMBO Journal
that ORP2 regulates endomembrane PI(4,5)P2 levels and FAK activa-
tion pending on its PI(4,5)P2 and cholesterol transfer.
FAK activation is known to be initiated by binding of its FERM
domain to PI(4,5)P2-containing membranes (Goni et al, 2014; Bauer
et al, 2019; Acebron et al, 2020). We therefore carried out biochemi-
cal fractionations of LDL-loaded control and acutely ORP2-ablated
cells. This showed that ORP2 enhances the membrane association
of FAK (Fig 7C). One possibility is that cholesterol, presumably
transferred by ORP2, contributes to the binding of FAK FERM to
PI(4,5)P2-containing membranes. To address this step in vitro,
we purified the FAK FERM domain and investigated its binding
to liposomes with defined lipid compositions. In liposome co-
sedimentation assays (Fig 7D), the membrane binding of FAK FERM
domain was increased by PI(4,5)P2 in a concentration-dependent
manner, as expected (Fig 7E and F). Addition of 20 mol% choles-
terol to membranes containing 1–2 mol% PI(4,5)P2 or 40 mol%
cholesterol to membranes containing up to 5 mol% PI(4,5)P2
further enhanced the membrane association of FERM (Fig 7E and
F). As an alternative strategy, we labeled the purified FERM domain
with Alexa488 and studied its binding to giant unilamellar vesicles
(GUVs) by imaging (Fig 7G). Control experiments confirmed that
the fluorescently labeled AF488-FERM binds to liposomes in a PI
(4,5)P2 concentration-dependent manner similarly as non-labeled
FERM (Fig EV5L). Addition of 30 mol% cholesterol to PI(4,5)P2-
containing GUVs increased the FERM domain membrane binding by
roughly twofold (Fig 7H). Together, these data argue that choles-
terol facilitates the association of FAK with PI(4,5)P2-containing
membranes.
Discussion
Here, we investigated the itinerary of LDL-derived cholesterol to the
PM. LDL particle hydrolysis by acid lipase is initiated in early endo-
somes (Sugii et al, 2003) and NPC1, a key gatekeeper for LDL-
cholesterol export, localizes to late endocytic organelles (Ko et al,
2001; Zhang et al, 2001) that communicate extensively with other
endomembranes. We found that rapidly after becoming accessible
in NPC1 organelles (after 1–2 h of LDL loading), LDL-cholesterol
becomes accessible in integrin recycling organelles. As the NPC1
and integrin recycling compartments do not mix, this implies that
LDL-cholesterol is transferred to integrin recycling organelles, which
also harbor the key adhesion regulator FAK.
Our results argue that cholesterol transfer from the NPC1 organelles
to recycling compartments is regulated by ORP2 (see Fig 8), as upon
acute degradation of endogenous ORP2, LDL-cholesterol does not
become accessible in integrin recycling compartments and FAK activa-
tion is attenuated. Importantly, ORP2 increases the membrane associa-
tion of FAK in LDL-loaded cells and cholesterol enhances themembrane
association of FAK FERM domain, a prerequisite for FAK activation.
Active FAK promotes PI(4,5)P2 generation in the endomembranes via
activation of PIPKIc (Nader et al, 2016). Our data further reveal that
endogenous ORP2 has affinity for endosomal PI(4,5)P2 and that ORP2
can promote the backtransfer of PI(4,5)P2 to NPC1 organelles. Which
proteins this late endosomal PI(4,5)P2 interactswith remains to be eluci-
dated but, based on our findings, it is likely involved in assembling
machineries for late endosomal dynamics and cargo export. Indeed, late
endosomal/lysosomal PI(4,5)P2 is considered to regulate kinesin-driven
◀ Figure 6. ORP2 regulates PI(4,5)P2 and NPC1 distribution.
A Endo-GFP-ORP2 cells were treated with control or OCRL siRNAs for 2 days, stained with PI(4,5)P2 antibody, and imaged by confocal microscopy.
B Cells stably expressing NPC1-mCherry were treated with control or OCRL siRNAs for 2 days, or transfected with GFP-ORP2 or -ORP2-mHHK (PI(4,5)P2 binding-
deficient mutant) for 1 day, stained with PI(4,5)P2 antibody, and imaged by confocal microscopy. For FAK inhibition, GFP-ORP2 transfected cells were treated with
10 lM PF-228 for 4 h. Dashed lines indicate cell edges. Arrowheads indicate colocalization of PI(4,5)P2 and NPC1.
C Quantification of (B). Values from control siRNA and Vector control were pooled and are shown as control siRNA/Vector control. Mean  SD, n = 20–43 cells pooled
from 2 independent experiments. Student’s t-test.
D, E Cells stably expressing NPC1-mCherry were transfected with GFP-ORP2 or GFP-ORP2-mHHK for 1 day and were indicated, treated with 10 lM PF-228 for 4 h. For
degron-ORP2 cells, NPC1-mCherry was transiently transfected for 2 days and cells incubated without (-IAA; ORP2 present) or with IAA (+IAA; ORP2 depleted) for
1 h. Arrowheads indicate tubular NPC1 organelles. Live cell images were acquired by widefield epifluorescence miroscopy and the longest NPC1 tubule per cell was
measured. Mean  SD, n = 102–122 cells. Students’s t-test. Please see also control (Movie EV4) and PF-228-treated cell (Movie EV5), both videos 1 min recordings
with 1 s frame rate.
▸Figure 7. Cholesterol dependent activation of FAK.A, B Control and degron-ORP2 cells were co-plated, and after 1-day 5% LPDS, treated with 50 lg/ml LDL and IAA (+IAA; ORP2 depletion) for the indicated times and
immunostained for pFAK to quantify its intensity. For rescue experiments, degron-ORP2 cells were plated and transfected with GFP-ORP2 or -ORP2-mHHK or -
ORP2-ΔELSK for 6 h. Cells expressing GFP-ORP2 constructs at levels similar to endo-GFP-ORP2 were used for quantifying pFAK intensity. Dashed lines indicate cell
outlines. See also Fig EV6C. Asterisk indicates cells depleted of endogenous ORP2. Images were acquired by confocal microscopy. Mean  SD, n = 20–23 cells
pooled from 2 independent experiments. Student’s t-test.
C Quantification of FAK protein in cytosolic and membrane fractions in degron-ORP2 cells with or without IAA. Cells were starved overnight in LPDS and loaded with
50 µg/mL LDL +/ IAA for 2 h. The proportion of FAK signal in the membrane fraction (of total FAK in cytosol + membranes) is presented  SD. For no IAA n = 13
and for IAA n = 11, 2 independent experiments. Student’s t-test.
D–F Liposome-co-sedimentation of FAK FERM with increasing concentrations of PI(4,5)P2 and cholesterol. “S” in (D) indicates the supernatant and “P” pellet containing
the FAK FERM-bound to liposomes. The total lipid concentration was kept at 50 lM, and purified FAK FERM concentration at 1 lM. The initial lipid composition
was POPC:POPE:POPS:Rhodamine-DHPE:PI(4,5)P2:cholesterol (70:19:10:1:0:0, mol/mol). The increasing PI(4,5)P2 and cholesterol concentrations were compensated
by decreasing the amount of POPC. Mean  SD, n = 5. Student’s t-test (*P < 0.05; **P < 0.002). Numbers under the blots indicate fraction of FAK FERM bound to
liposomes (pellet) of total FAK FERM (supernatant + pellet).
G, H Binding of Alexa Fluor 488-labeled FAK FERM domain to GUVs containing PI(4,5)P2 and cholesterol. The lipid compositions were POPC:POPE:POPS:Rhodamine-
DHPE:PI(4,5)P2:cholesterol (50:19:10:1:20:0) and POPC:POPE:POPS:Rhodamine-DHPE:PI(4,5)P2:cholesterol (20:19:10:1:20:30, mol/mol). Images were acquired by
widefield epifluorescence microscopy. Scale bar, 5 lm. Mean  SD, n = 68–76 pooled from 2 independent experiments. Student’s t-test.
Source data are available online for this figure.
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organelle movement and nucleation of lysosomal scission machinery
(Ebner et al, 2019; Saffi & Botelho, 2019).
The present study employed for the first time rapid (mins-to-hrs)
protein perturbation to investigate the function of endogenous ORP2.
This is relevant in lipid trafficking/metabolism where the removal of a
single gene product can be accompanied by complex adaptive
changes. For instance, inducible ORP2 overexpression for 2 days
enhanced cholesterol efflux to extracellular acceptors, decreased cellu-
lar cholesterol, and resulted in upregulation of cholesterol synthesis
and LDL uptake (Hynynen et al, 2005). We also detected ORP2 ligands
using strategies that per se do not affect lipid trafficking/distribution
(as e.g., intracellular overexpression of lipid-binding protein domains
might do): Accessible cholesterol was detected with the biosensor
D4H applied extracellularly and PI(4,5)P2 by antibodies only post, not
during the process under study (e.g., LDL loading, FAK inhibition). Of
note, in most experiments LDL was loaded into cells for increasing
times. Hence, the NPC1 compartment is not getting emptied of LDL-
cholesterol and the relative contribution of NPC1 vs. FAK/integrin
endosomes in LDL-cholesterol PM delivery cannot be specified. This
may also vary between cells: e.g., in motile cells, where the turnover
of adhesions is accelerated, the integrin recycling circuit route might
play amore prominent role than in statically adherent cells.
We found endogenous GFP-ORP2 in the vicinity of NPC1 and inte-
grin/FAK containing organelles. Tracing their communication with
LDL-derived BODIPY-cholesterol revealed rapid kiss-and-run like
endosome contacts, suggesting that ORP2-mediated lipid exchange
occurs during such transient contacts. Long-term membrane
anchoring of ORP2 would not be needed in such a scenario (Wang
et al, 2019), as opposed to, e.g., more stable ORP2 binding to the ER
via VAPs (Weber-Boyvat et al, 2015). Rather, ORP2 function—
presumably in lipid exchange, to govern the correct membrane lipid
compositions—appears important for maintaining the transient
nature of contacts between late and recycling endosomal compart-
ments, as such contacts became fewer in number and longer-lasting
rapidly upon ORP2 removal.
Based on structural information, the cholesterol-bound ORP2 is
monomeric and the PI(4,5)P2-bound one tetrameric (Wang et al,
2019), i.e., four cholesterol molecules would be transported from late
to recycling organelles by ORP2 monomers that assemble to a
tetramer to transport four PI(4,5)P2 molecules back. Cholesterol
transfer from LDL-loaded late endosomes to recycling endosomes is
likely down the concentration gradient; hence, PI(4,5)P2 hydrolysis
would not be needed to energize it but PI(4,5)P2 could instead be used
for assembling endosomal PI(4,5)P2-interacting proteins. Of note, our
data do not conclusively rule out ORP2 function in cholesterol-PI(4,5)
P2 exchange between endosomes and the PM, but since endogenous
ORP2was not concentrated in the PM and a detectable PM enrichment
of PI(4,5)P2 only developed with a lag upon ORP2 removal, a primary
lipid exchange function at the level of endosomes appearsmore likely.
Instead, we found no evidence that LDL-cholesterol trafficking toward
the ERwould be perturbed immediately upon ORP2 degradation.
Our findings reveal a previously unsuspected role for FAK in control-
ling LDL-cholesterol delivery and regulating NPC1 organelle dynamics.
If FAK is inactive, NPC1 organelles undergo excessive tubulation and
Figure 8. Schematic of LDL-cholesterol delivery to the PM.
LDL-cholesterol is taken up via LDL receptor-mediated endocytosis and the liberated free cholesterol is incorporated into late endosomal limiting membrane via NPC2
and NPC1. ORP2 delivers cholesterol from late endosomes to FAK/integrin recycling endosomes where cholesterol facilitates FAK association with the PI(4,5)P2-containing
membrane. Activated FAK increases the activity of endosomal PIPKIc which generates PI(4,5)P2, accelerating the recycling of active integrins. ORP2 unloads PI(4,5)P2 from
FAK/integrin endosomes and delivers it to NPC1-containing late endosomes, regulating their tubulovesicular dynamics. This coupling of ORP2 and FAK activity drives
efficient cholesterol delivery to the plasma membrane, stimulating FA dynamics and cell migration.
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fail to reach the peripheral sites close to FAs. As overexpression of PI
(4,5)P2 transfer-competent (but not incompetent) ORP2 promotes
peripheral scattering of NPC1 organelles and can bypass FAK activation
in limiting NPC1 tubulation, PI(4,5)P2 generation enhanced by FAK is
probably one, if not the sole function of FAK in LDL-cholesterol deliv-
ery. Overexpressed ORP2 can probably transfer PI(4,5)P2 indepen-
dently of endosomal PIPKIc activity, for instance from the PM, and
thereby circumvent the need for FAK. Physiologically, ORP2 cross-talks
with FAK, with ORP2-mediated cholesterol transfer stimulating FAK
membrane association and activation, and FAK activity promoting PI
(4,5)P2 generation for ORP2-mediated transfer. This cross-talk may be
relevant for the in vivo function of ORP2: Themechanosensory bundles
of auditory cells are composed of cilia, which depend on FAK (Antoni-
ades et al, 2014), ORP2 knockout pigs had degenerated stereocilia (Yao
et al, 2019) and ORP2-deficient cochlear cells displayed inhibited FAK
activity (Shi et al, 2020). To conclude, the present study pinpoints the
activity of ORP2 in cholesterol-PI(4,5)P2 transfer between late and recy-
cling endosomes, in concert with a new function of FAK in controlling
late endosomal trafficking and cholesterol egress.
Materials and Methods
Materials
Human LDL was prepared from pooled plasma of healthy volunteers
by sequential ultracentrifugation, and lipoprotein-deficient serum
was prepared as described in (Goldstein et al, 1983). DiI-LDL was
prepared as described in (Reynolds & St Clair, 1985). BODIPY-
cholesteryl linoleate was synthesized and used to label human LDL
as described (Kanerva et al, 2013). Methyl-b-cyclodextrin (C4555),
PF-228 (PZ0117) and U18666A (C3633) were obtained from Sigma.
Indole-3-acetic acid sodium (IAA, Santa Cruz, sc-215171) was
prepared at 100× in H2O (10 mg/ml), aliquoted, stored at 20°C and
used within 2 days after thawing. Antibodies: pFAK (BD Transduc-
tion Laboratory #611807, clone 18 for Western blotting and
Thermo Fisher #44-624G for immunofluorescence), FAK (Sigma
05-537, Clone 4.47), integrin b1 (Santa Cruz sc-18887, K20 for
immunofluorescence and Sigma MAB2252, clone N29 for Western
blotting), PI(4,5)P2 (Echelon, Z-G045, clone 2C11), ORP2 (Novus
Biologicals, NBP1-92236), NPC1 (Abcam, ab134113), Lamp1
(DSHB, H4A3), GFP (Abcam, ab290 and ab1218); see Appendix Fig
S1 for specificity controls of pFAK, FAK, and integrin b1antibod-
ies. Lipids: 1-palmitoyl-2oleoyl-sn- glycero-3-phosphocholine (POPC),
1-palmitoyl-2oleoyl-sn-glycero-3-phosphoethanolamine (POPE), 1-
palmitoyl-2oleoyl-sn-glycero-3-phospho-L-serine (sodium salt) (POPS),
L-a-phosphatidylinositol-4,5-bisphosphate (brain, porcine, ammonium
salt; brain PI(4,5)P2), cholesterol (ovine) were from Avanti Polar
Lipids. LisssamineTM rhodamine B 1,2-dihexadecanoyl-sg-glycero-3-
phosphoethanolamine, triethylammonium salt (rhodamine-DHPE)
was from ThermoFisher Scientific. PI(4,5)P2 was dissolved in
chroloform:methanol:H2O (20:9:1) and other lipids in choroloform.
Cell culture and transfection
Human epithelial carcinoma A431cells (ATCC, Cat#CRL-1555) were
maintained in Dulbecco’s modified Eagle’s medium (Lonza) contain-
ing 10% FBS (Gibco), penicillin/streptomycin (100 U/ml each,
Lonza), and 2 mM L-glutamine (Gibco) (complete medium, CM) at
37°C in 5% CO2. For LDL depletion, cells were incubated in DMEM
supplemented with 5% LPDS prepared as described in (Goldstein
et al, 1983) for ~ 1 day, and 50 lg/ml LDL was loaded for the indi-
cated times. Transfections were performed with X-tremeGENE HD
Transfection Reagent (Sigma) for plasmids and HiPerFect (Qiagen)
for siRNAs according to the manufacture’s protocol.
Plasmids and siRNAs
The following plasmids were obtained from Addgene: mCherry-talin
(Addgene plasmid #80026) (Lee et al, 2013), mCherry-FAK (#55122),
GFP-FAK (#50515) (Gu et al, 1999), GFP-FAK Y397F (#50516), and
iRFP-PH-PLCdelta1 (#66841) (Idevall-Hagren et al, 2012). GFP-paxillin
was provided by Dr Pekka Lappalainen (University of Helsinki). GFP
or mCherry was linked to the C-terminus of NPC1 and cloned into the
safe harbor vector pSH-FIRE-P-AtAFB2 (Addgene, #129715) (Li et al,
2019) to obtain pSH-NPC1-GFP or -mCherry. GFP-ORP2, phospho-
inositide binding-deficient (mHHK: H178–179A, K423A), and sterol non-
binding (ΔELSK: deletion of residues 430–433) mutant in pEGFP-C1
were described in REF (Weber-Boyvat et al, 2015). mCherry-D4H
cDNA in mCherry-C1 vector was provided by Dr Gregory G. Fairn
(University of Toronto) (Maekawa & Fairn, 2015). The D4H domain
was PCR-amplified and inserted into pGEX6P-1 with N-terminal
sfGFP- or mCherry-tag. Human FAK FERM domain (34–362) was
PCR-amplified from mCherry-FAK incorporating EcoRI and XhoI
restriction sites and inserted into pGEX6P-1 (GE Life Sciences). The
following siRNAs (from Ambion) were used: silencer select negative
control #1, FAK siRNA (GAUGUUGGUUUAAAGCGAUtt, ID: s11485)
integrin b1 siRNA (CCGUAGCAAAGGAACAGCAtt, ID: 7574), OCRL
siRNA (GGGUCUCAUCAAACAUAUCtt, ID: 104450), and ORP2 siRNA
(CACUCUUGGGAGAAACGUAtt, ID: s19149).
Protein purification
pGEX6P-sfGFP/mCherry-D4H was transformed into BL21 (DE3)
competent cells, and protein expression was induced with 0.4 mM
isopropyl-b-D-thiogalactopyranoside (IPTG, Sigma) at 16°C over-
night. The cell pellet was lysed and sonicated in lysis buffer (50 mM
NaH2PO4/Na2HPO4, 300 mM NaCl, pH 8.0) complemented with
1 mM benzamidine, 10 lg/ml chymostatin, 10 lg/ml leupeptin,
2 lg/ml pepstatin A, and 0.4 mM PMSF (Sigma). The lysate was
centrifuged at 12,000 g for 10 min at 4°C. The supernatant was incu-
bated with pre-equilibrated Glutathione Sepharose 4B beads (GE Life
Sciences) for 2 h at 4°C. The resin was washed with lysis buffer, the
GST-tag was removed with PreScission protease (GE Life Sciences),
and sfGFP- or mCherry-D4H was eluted with elution buffer (20 mM
NaH2PO4/Na2HPO4 pH 7.4). pGEX6P-1-FAK FERM was transformed
into BL21 (DE3) competent cells, and protein expression was induced
with 0.2 mM IPTG at 18°C overnight. The cell pellet was lysed and
sonicated with lysis buffer A (50 mM Tris–HCl, pH 8.0, 250 mM
NaCl) complemented with 1 mM EDTA, 1 mM TCEP, 1 mM benza-
midine, 10 lg/ml leupeptin, 1 mM PMSF, 10 mg/ml lysozyme, and
0.5 mg/ml DNase. The lysate was treated with 1% Triton X-100 for
15 min at 4°C and centrifuged at 12,000 g for 10 min. The super-
natant was incubated with pre-equilibrated Gluthatione Sepharose
4B beads in buffer B (50 mM Tris–HCl, pH 7.0, 250 mM NaCl, 1 mM
EDTA, 1 mM TCEP and 1% Triton X-100) for 2 h at 4°C. The resin
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was washed with buffer B, the GST-tag was removed with PreScission
protease, and FAK FERM was eluted with elution buffer (50 mM
Tris–HCl, pH 7.4, 150 mM NaCl, 1 mM EDTA, and 1 mM TCEP). For
fluorescent labeling, ten-times molar excess of Alexa 488 maleimide
(Life Technologies) was added to react with cysteines overnight at
4°C. Excess dye was removed by dialysis (MWCO 6-8000) in 20 mM
Tris–HCl, pH 7.5, 150 mM NaCl, and 1 mM EDTA. Purified D4H and
FAK FERMwere stored at20 and80°C, respectively.
D4H staining of cells
For plasma membrane D4H staining, cells were grown on glass
cover slips, incubated in sfGFP- or mCherry-D4H solution (10 lg/ml
in PBS, 1% BSA) for 30 min on ice, washed with ice-cold PBS once,
and fixed with 4% PFA for 15 min. Cover slips were rinsed in H2O
and mounted on slides using Mowiol/DABCO (Calbiochem/Sigma).
For intracellular D4H staining, cells were grown on glass cover slips,
fixed with 4% PFA, permeabilized in a liquid nitrogen bath for 30 s
as described (Wilhelm et al, 2017), and incubated with D4H solution
(10 lg/ml in PBS, 1% BSA) at RT for 1 h. Cells were then washed
with PBS, re-fixed with 4% PFA for 15 min, and blocked with 1%
BSA in PBS at RT for 30 min. Primary antibodies were incubated at
RT for 1 h followed by incubation with Alexa Fluor-conjugated
secondary antibodies at RT for 1 h.
Quantification of FA dynamics
To analyze FA dynamics, cells were transfected with GFP-paxillin,
mCherry-talin, GFP-FAK, or GFP-FAK Y397F plasmids and plated on
fibronectin-coated (5 lg/ml) glass bottom l–slide 4-well plates
(Ibidi), to promote integrin-dependent cell adhesion mechanisms.
Single cells were chosen and images acquired every 30 s for 1–2 h,
using a Nikon eclipse-Ti-E N-STORM microscope, equipped with
Andor iXon+ 897 back-illuminated EMCCD camera and 100× Apo
TIRF oil objective, NA 1.49. For LDL loading, cells were LDL
depleted in 5% LPDS for 1 day, and incubated with 50 lg/mL LDL
in DMEM for the indicated time points. FA assembly and disassem-
bly rates were analyzed by uploading the videos to FA analysis
server (FAAS; http://faas.bme.unc.edu/) using the following
settings: detection threshold, 2.5; Min adhesion size, 2; Phase
length, 5 images; Min FAAI ratio, 3. For NPC1 and FAK kinase inhi-
bition, 2 lg/mL U18666A or 10 lM PF-228 was added after 30 min
of LDL loading. For cholesterol depletion, cells were treated with
5 mM methyl-b-cyclodextrin for 30 min. Unless otherwise noted,
images were acquired during 1–3 h of LDL loading.
Fixed and live-cell widefield epifluorescence imaging
Cells were imaged with Nikon eclipse-Ti-E microscope equipped
with Nikon Perfect Focus System 3, Hamamatsu Flash 4.0 V2 scien-
tific CMOS and Okolab stage top incubator system. For plasma
membrane D4H imaging, 40× Fluor oil objective NA 0.75 was used
and fields of cells were randomly acquired. Imaging was carried out
at ~ 60–70% cell confluency and mean fluorescence intensity of
non-cell region in the same image was used for background subtrac-
tion. For live-cell imaging (Figs 6D and EV5H), 100× Plan Apo VC
oil objective was used. Cells were seeded onto 1 l-slide 8-well
ibiTreat chambers coated with 5 lg/ml fibronectin and imaging was
performed at 37°C, 5% CO2. For the movies, cells were imaged with
1 s frame rate for 1 min.
Fixed and live-cell confocal imaging
All images were acquired at ~ 60–70% cell confluency, and cells
migrating toward the free space were chosen for imaging. Cells were
imaged with Zeiss LSM 880 equipped with an Airyscan detector using
a 63× Plan Apochromat oil objective NA 1.4, with sequential excita-
tion of fluorophores using appropriate lasers and stable emission filter
sets. The Airyscan detector was adjusted regularly between acquisi-
tions. Images were Airyscan processed automatically using the Zeiss
Zen software package. For intracellular D4H quantification, fraction
of D4H area overlapping with other organelles in a peripheral region
toward the leading edge per cell was analyzed (to avoid the perinucle-
arly clustered signal). Images were thresholded, and quantified using
Mander’s overlap coefficient as a measure of colocalization. For PI
(4,5)P2 quantification (Fig 6B and C), mean fluorescence intensity or
fraction of NPC1 area overlapping with PI(4,5)P2 per cell was
analyzed. Imaging was done within 24 h after fixation. For live-cell
imaging, cells were seeded onto 8-well Lab-Tek II #1.5 coverglass
slides coated with 5 lg/ml fibronectin and imaging was performed at
37°C, 5%CO2. Mediumwas replacedwith FluoroBrite DMEM (Thermo
Fisher Scientific) before live-cell imaging. For plasma membrane PI
(4,5)P2 imaging, cells were transfected with iRFP-PH-PLCdelta1 for
overnight and imaged live.
BODIPY-cholesteryl linoleate/LDL pulse-chase and imaging
Cells seeded on fibronectin-coated 4-well Lab-Tek II #1.5 coverglass
slides were grown overnight in 5% LPDS medium supplemented
with 50 lg/ml Alexa Fluor 568-dextran (Thermo Fisher Scientific)
as indicated and then pulse-labeled with 50 lg/ml BODIPY-
cholesteryl linoleate/LDL in serum-free DMEM for 2 h as described
(Kanerva et al, 2013). For detection of integrin or transferrin, cells
were incubated with 2 µg/ml Alexa Fluor 680-conjugated integrin
b1 antibody (K20, Santa Cruz, sc-18887) for 30 min or with 50 lg/ml
Alexa Fluor 647-labeled human transferrin (Thermo Fisher Scien-
tific) for 15 min before imaging. Cells were then washed and chased
in serum-free CO2-independent medium (Gibco) for the indicated
times and imaged live at 37°C. Confocal imaging was performed on
a Leica TCS SP8 X inverted microscope (Leica Microsystems) with
×63 HC PL APO CS2 water objective, NA 1.20. For time series, single
focal planes were imaged with 145 ms frame rate for 1 min. The
fraction of BODIPY-cholesterol residing in integrin b1-positive or
transferrin organelles was quantified from deconvolved (SVI
Huygens), background-subtracted images with ImageJ FIJI by using
Mander’s overlap coefficient as a measure of colocalization. The
increase in organellar BODIPY-cholesterol intensity was analyzed by
measuring BODIPY-cholesterol mean intensity in integrin b1-
positive organelles either contacting or not contacting with other
organelle/s in the same time series.
Dextran and transferrin pulse-chase and imaging
Degron ORP2 cells seeded on Lab-Tek II slides were grown over-
night in 5% LPDS, serum-starved for 1 h, and then incubated with
50 µg/ml LDL and 500 µg/ml fluorescein dextran (Thermo Fisher
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Scientific, D1820) for 2 h. After washing, the cells were loaded for
15 min with 50 µg/ml Alexa Fluor 647-labeled human transferrin
and washed again. IAA (100 µg/ml) was added simultaneously with
LDL and kept on during the chase. The cells were chased and
imaged as in BODIPY-cholesteryl linoleate/LDL experiments except
that imaging was performed with 369 ms frame rate. Trajectories of
double-positive organelles were traced and measured with ImageJ
FIJI using Manual Tracking plugin. Dark pixels between organelles
was considered as lack of contact. To measure the number of orga-
nelle contacts, individual dextran positive organelles were followed
for 7 s and the number of transferrin organelles touching a dextran
organelle during this time was quantified.
Immunofluorescence microscopy
Cells were grown on coverslips, fixed with 4% PFA for 15 min, perme-
abilized with 0.1% Triton X-100 for 10 min and blocked with 1% BSA
in PBS for 30 min at RT. Cells were then stained with primary antibody
for 1 h at RT followed by secondary antibody for 1 h at RT. Cover slips
were rinsed in H2O and mounted on slides using Prolong glass antifade
reagent (Thermo Fisher Scientific). For detection of internalized inte-
grin b1, cells were incubated with 2 lg/ml integrin b1 at 37°C for
30 min before fixation, permeabilized, and incubated with Alexa
Fluor-conjugated secondary antibody. For pre-fixation permeabiliza-
tion, cells were washed with DPBS and permeabilized with 0.0025%
saponin in 10 mMMES, pH 6.1, containing 138 mMKCl, 3 mMMgCl2,
2 mMEGTA, and 320 mM sucrose for 1 min at 37°C. Cells were gently
washed with DPBS and fixed with 4% PFA for 20 min. Immunostain-
ing of endomembrane PI(4,5)P2was performed as previously described
(Hammond et al, 2009), except that PBS was used as buffer and 1%
BSA for blocking. Briefly, cells were fixed, permeabilized with 20 lM
digitonin for 5 min, blocked with 1% BSA, and stained with PI(4,5)P2
antibody. Endomembrane pFAK antibody staining was performed in
the samemanner as endomembrane PI(4,5)P2 staining.
Western blotting
Cells were washed with ice-cold PBS and lysed in buffer containing
HEPES pH 7.4, 1% NP40, 150 mM NaCl, 5 mM EDTA, 25 lg/ml
chymostatin, 25 lg/ml leupeptin, 25 lg/ml antipain hydrochloride,
25 lg/ml pepstatin A, 10 mM sodium fluoride, 10 mM orthovana-
date, and 1 mM PMSF. Equal amounts of protein were loaded onto
Mini-Protein TGX Stain-Free gels and transferred onto PVDF
membrane. Membranes were blocked with 1% BSA or 5% skim milk
in TBS containing 0.1% Tween-20 for 30 min, and subsequently
probed with primary antibodies at 4°C overnight. After washing with
TBS containing 0.1% Tween-20, membranes were incubated with
secondary antibodies at RT for 1 h. Membrane were washed, incu-
bated with ECL Clarity (Bio-Rad, Cat#170-5061), and imaged with a
ChemiDoc MD Imaging System (Bio-Rad). Band intensities were
analyzed by using ImageJ software and normalized to total protein
content quantified with the Stain-Free technology (Bio-Rad).
Generation of endo-mEGFP-ORP2 and Degron-mEGFP-ORP2 cells
N-terminal miniIAA7-mEGFP tagging of endogenous ORP2 loci was
conducted with CRISPR-Cas9-mediated homology-directed repair
(HDR) as previously described (Li et al, 2019). For constructing
donor vector, homology arms were amplified from A431 genomic
DNA using primers: CTCACTGCGATCTCTGCCTC and GGGTTTCA
GGCTCTTCCCTG for LH-RH, to be used as templates for LH and RH
separately, with primers CTCACTGCGATCTCTGCCTC and AGCCCT
CCATCCTTCAGCAGCCAGCCTCC for LH, and GGGTTTCAGGCTC
TTCCCTG and AGGCGGATCCAACGGAGAGGAAGAATTCTTTGATG
CCG for RH. MiniIAA7-mEGFP tag was amplified from pGL3-
miniIAA7-mEGFP-LMNA (Li et al, 2019) using primers: (CTGC
TGAAGGATGGAGGGCTTCTCTGAGACCG and CCTCTCCGTTGGAT
CCGCCTCCGCCAGAT). Overlap PCR was performed to assemble
PCR fragments (LH, MiniIAA7-mEGFP and RH as templates) using
primers: ATGCACGCGTGGGACTATAGGCGTGCGCC and ATGCGT
CGACTCACATGCCCATGAGCCCTG. The PCR fragment was then
cloned into pGL3 vector using Sall and Mlul restriction sites to
obtain pGL3-miniIAA7-mEGFP-ORP2 vector. SgRNAs (sense: CACC
GCTGCTGAAGGATGAACGGAG, antisense: AAACCTCCGTTCATCC
TTCAGCAGC) were synthesized as two unphosphorylated primers,
annealed and inserted into Bbsl-cut pCas9-sgRNA vector. Cells were
transfected with the pGL3-miniIAA7-mEGFP-ORP2 and pCas9/
sgRNA and selected with 1 lg/ml puromycin for 2 days to eliminate
untransfected cells and high mEGFP-ORP2 expressing cells were
enriched from the HDR pool by FACS and single clones were
selected by limited dilution. To generate Degron-mEGFP-ORP2 cells,
the homozygously tagged single clone was transfected with pCas9s-
gAAVS1 and pSH-EFIRES-P-AtAFB2 and selected with 1 lg/ml puro-
mycin for 6 days. To sequence the modified genome region,
genomic DNA was extracted by NucleoSpin Tissue (Macherey-
Nagel, 740952), amplified by PCR using primers (forward: TTCT
GGAAGCTAAGTATGC, reverse: CACACACTGCTTTACTGAG), puri-
fied and DNA sequencing was performed using the same primers
(Appendix Fig S2). MiniIAA7-mEGFP-ORP2 cells, which do not
express AtAFB2, were used as a control. For ORP2 depletion,
degron-ORP2 cells were treated with 100 lg/ml indole-3-acetic acid
(IAA) for the indicated time.
Quantitative reverse transcription PCR
Total RNAs were isolated using the NucleoSpin RNA isolation kit
(Macherey-Nagel, 740955-250), and 1 lg of total RNA was tran-
scribed using SuperScript VILO cDNA synthesis kit (Invitrogen).
Quantitative reverse transcription PCR was performed using Light
Cycler 480 SYBR Green I Master Mix (Roche) and a Light Cycler 480
II (Roche). Reaction steps: 95°C for 15 min and 40 cycles of 95°C
15 s, 60°C 30 s, and 72°C 10 s. Relative quantities of mRNAs were
normalized to 18S. Primers for 18S: GTCTTGTAGTTGCCGTCGTCC
TTG (forward) and GTCTTGTAGTTGCCGTCGTCCTTG (reverse),
for 3-Hydroxy-3-Methylglutaryl-CoA Reductase (HMGCR): ATGGA
AACTCATGAGCGTGGT (forward) and AGCTCCCATCACCAAGGA
GT (reverse), and for LDL receptor: TGGCTGCGTTAATGTGACA
CTC (forward) and AGCCGATCTTAAGGTCATTGC (reverse).
[3H]oleic acid incorporation into cholesteryl esters
For analyzing LDL-induced cholesterol esterification, degron-ORP2
and control cells were cultured in 5% LPDS for 24 h, washed with
PBS, and treated with 50 lg/ml LDL for 0–6 h. Cells were then
supplemented for 2 h with [3H]oleic acid (5 lCi/ml, Perkin Elmer)
in 2% defatted BSA prepared in 5% LPDS medium. During LDL and
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oleic acid loading, the degron-ORP2 cells were supplemented with
100 lg/ml IAA as indicated. The cells were collected by scraping in
cold 2% NaCl and lipids were extracted as described (Bligh & Dyer,
1959). Dried lipids were dissolved in chloroform/methanol (9:1),
resolved by TLC using hexane/diethyl ether/acetic acid (80:20:1) as
the mobile phase and dried plates were stained with iodine vapor.
The cholesteryl ester bands were scraped and radioactivity
measured by liquid scintillation counting. The results were
corrected for the volume and procedural losses and plotted against
the total amount of protein in the sample.
Transferrin uptake
Cells were seeded in 24-well plates (75,000 cells per well) with four
replicates for each time point/treatment. A separate identical plate
was prepared for quantification of surface transferrin receptor.
On the following day, cells were serum-starved at 37°C with pre-
warmed serum-free media (containing or not the respective chemi-
cal treatments for each condition) for 1 h before the experiment.
Methyl-b-cyclodextrin was used at 5 mM for 1 h. For uptake
experiments, 10 lg/ml Alexa Fluor-647-labeled human transferrin
(Thermo Fisher Scientific, T23366) were added to cells at 37°C for
8 min. For the quantification of surface transferrin receptor, cells
were placed on ice and incubated with Alexa Fluor-647-labeled
human transferrin (10 lg/ml) for 1 h. After incubation, cells were
washed with PBS, detached with trypsin (for uptake experiments)
or Accutase (Sigma, A6964) (for surface receptor measurement)
followed by addition of ice-cold serum-containing media. Cells were
transferred to 1.5-ml tubes, spun, washed with ice-cold PBS, and
fixed with 4% PFA for 10 min at 4°C. Fixed cells were spun to
remove fixative, resuspended in PBS, and transferred to FACS tubes.
Fluorescence was measured using a BD LSR Fortessa flow cytometer
(BD Biosciences) using appropriate filters. For each condition, 5,000
cells were measured. The median value for each replicate was used
as a single experimental point. Normalized transferrin uptake was
calculated by dividing the fluorescence signal of the uptake experi-
ment for each condition by the average fluorescence signal of the
surface receptor experiments for the same condition.
Cell fractionation
Cells were washed with PBS on ice, scraped in PBS, and centrifuged
at 2,000 rpm (380 g) for 10 min at 4°C. The cell pellets were resus-
pended in PBS containing 10 mM sodium fluoride, 10 mM ortho-
vanadate, 1 mM PMSF, 25 lg/ml chymostatin, 25 lg/ml leupeptin,
25 lg/ml antipain hydrochloride, and 25 lg/ml pepstatin A, passed
through a 25-gage needle for 100 times and centrifuged at
6,000 rpm (3,420 g) for 10 min at 4°C. The supernatant (post
nuclear fraction) was centrifuged in a TLA-100 rotor at 50,000 rpm
(109,000 g) for 1 h at 4°C. The supernatant (cytosol) and the pellet
(membrane) were resuspended in PBS containing above inhibitors
and SDS sample buffer. Both cytosol and membrane samples were
boiled for 10 min and similar volumes loaded for Western blotting.
Protein binding to liposomes and GUVs
Lipid compositions are indicated in the figure legends. A 1 mM lipid
solution was mixed, dried under a stream of nitrogen gas and dried
further by Speedvac for 1 h, hydrated in HEPES (pH 7.4) with
100 mM NaCl, and vortexed for 1 h. Liposome co-sedimentation
was performed with concentration of 50 lM lipids and 1 lM puri-
fied FAK FERM protein. The protein was pre-cleared by centrifuga-
tion at 100,000 rpm (436,000 g) for 30 min at 4°C with an Optima
MAX Ultracentrifuge equipped with TLA-100 rotor (Beckman Coul-
ter, Inc) to remove aggregates. Then, liposomes and protein were
mixed and incubated at RT for 30 min, the mixture was centrifuged
at 100,000 rpm (436,000 g) for 30 min. The pellet was collected as
the bound fraction and supernatant as the non-bound fraction. For
measuring protein binding to GUVs, a 5% (w/w) solution of poly-
vinyl alcohol (PVA, MW 145,000, Merck KGaA) was prepared by
stirring PVA in water while heating at 90˚C. PVA-coated substrates
were prepared by spreading 20 ll of PVA solution on a microscope
coverslip (18 mm in diameter), which was then dried for 30 min at
50°C. 10 ll of lipids dissolved in chloroform (1 mM) were spread
on the dried PVA film and placed under vacuum for 30 min to evap-
orate the solvent. The lipid film was allowed to swell for 1 h in
500 ll of 5 mM HEPES (pH 7.4), 100 mM NaCl, and 20 mM
sucrose. The formed GUVs were collected and incubated with 1 lM
Alexa 488-labeled FAK FERM protein for 30 min. The coverslips
were coated with b-casein (Sigma) to avoid non-specific protein
binding. Images were acquired with Nikon Eclipse Ti-E microscope,
x100 PlanApo VC oil objective.
Image quantification
Quantifications were performed with ImageJ FIJI. Background-
subtracted images were quantified as mean intensity or using
Mander’s overlap coefficient as a measure of colocalization.
Statistical analysis
Statistical significance was determined by Non-parametric Kruskal–
Wallis analysis of variance with Bonferroni error correction, two-
tailed and paired (where indicated) Student’s t-test, or one-way
ANOVA with Tukey’s post hoc test. The number of replicates (n)
used for calculating statistics is specified in the Figure legends. Dif-
ferences were considered statistically significant at P < 0.05. Results
are expressed as mean  SD or  SEM of the indicated number of
observations.
Data availability
This study includes no data deposited in external repositories.
Expanded View for this article is available online.
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